论文部分内容阅读
肿瘤导向是当前十分活跃的研究领域,近来,随单克隆抗体技术的发展,用放射性核素标记抗肿瘤单克隆抗体作肿瘤定位及治疗已引起普遍的关注。 我们自1986年起,用~(131)I标记抗人肝癌细胞系(BEL-7402)单克隆抗体(Hepama I),
Tumor targeting is currently a very active research field. Recently, with the development of monoclonal antibody technology, the use of radionuclide labeled anti-tumor monoclonal antibodies for tumor localization and treatment has attracted widespread attention. Since 1986, we have used ~(131)I to label anti-human hepatoma cell line (BEL-7402) monoclonal antibody (Hepama I),